Search results for "From ACP Diabetes Monthly"

Results 1 - 2 of about 2 for "From ACP Diabetes Monthly".

Incretin-based drugs not associated with any increase in risk for pancreatic diseases

population to study people with type 2 diabetes diagnosed after 2004 who received metformin plus a dipeptidyl peptidase-4 inhibitor (DPP-4) (n=50,095), glucagon-like peptide-1 (GLP-1) ... All articles from the November 27, 2018, ACP Gastroenterology
November 2018

Metformin use associated with improved outcomes in patients with historical contraindications

Studies were included in the review if they were published in English and included adults with type 2 diabetes and CKD, CHF, or chronic liver disease with hepatic impairment; compared regimens ... All articles from the January 27, 2017, ACP
January 2017

Result Page: Prev   1   Next